FDA unveils second batch of commissioner voucher winnersnews2025-11-06T20:07:01+00:00November 6th, 2025|Endpoints News|
Updated: Trump lands sweeping cost cuts on Lilly, Novo weight loss drugsnews2025-11-06T17:04:00+00:00November 6th, 2025|Endpoints News|
Novo Nordisk raises Metsera bid again, hoping to top Pfizer’s latest offernews2025-11-06T15:56:47+00:00November 6th, 2025|Endpoints News|
Dyne changes plans for DM1 drug again; Dynavax licenses Vaxart’s Covid vaccinenews2025-11-06T15:43:37+00:00November 6th, 2025|Endpoints News|
#ASN25: Vera outlines full Phase 3 win for kidney drug, preps for FDA filing by year’s endnews2025-11-06T15:11:58+00:00November 6th, 2025|Endpoints News|
UPS, Cencora to expand their US operations; Evotec divests biosimilar business to Sandoznews2025-11-06T14:36:04+00:00November 6th, 2025|Endpoints News|
J&J’s Caplyta approved by FDA as add-on treatment for depressionnews2025-11-06T14:20:11+00:00November 6th, 2025|Endpoints News|
How UpToDate plans to compete in the race for doctors’ AI search toolsnews2025-11-06T14:00:00+00:00November 6th, 2025|Endpoints News|
Oura’s healthcare ambitions take shapenews2025-11-06T13:59:15+00:00November 6th, 2025|Endpoints News|
Low vaccine uptake hampers Moderna earnings, including meager RSV salesnews2025-11-06T12:00:52+00:00November 6th, 2025|Endpoints News|
